Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

Anti-Human KRT19/CK19 Nanobody (SAA1367)

Catalog #:   RHC36001 Specific References (36) DATASHEET
Host species: Alpaca
Isotype: VHH-8His-Cys-tag
Applications: ELISA, FCM, IHC, IP, WB
Expression system: Mammalian Cells
Overview

Catalog No.

RHC36001

Expression system

Mammalian Cells

Species reactivity

Human

Host species

Alpaca

Isotype

VHH-8His-Cys-tag

Clonality

Monoclonal

Target

CK-19, Cytokeratin-19, K19, KRT19, Keratin-19, Keratin, type I cytoskeletal 19

Concentration

1.63 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Purified by Nickel column.

Accession

P08727

Applications

ELISA, FCM, IHC, IP, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

SAA1367

Data Image
  • SDS-PAGE
    SDS PAGE for Human KRT19/CK19 Nanobody
References

Distinct CTC Specific RNA Profile Enables NSCLC Early Detection and Dynamic Monitoring of Advanced NSCLC., PMID:40178328

Intratumoral NKT cell accumulation promotes antitumor immunity in pancreatic cancer., PMID:38980903

Plasma proteomic profiling reveals KRT19 could be a potential biomarker in patients with anti-MDA5+ dermatomyositis., PMID:37160775

Duplex Phenotype Detection and Targeting of Breast Cancer Cells Using Nanotube Nanoprobes and Raman Imaging., PMID:36795958

Carcinomas assemble a filamentous CXCL12-keratin-19 coating that suppresses T cell-mediated immune attack., PMID:35046049

Biliary atresia-specific deciduous pulp stem cells feature biliary deficiency., PMID:34809720

Comparison of the biological and functional characteristics of mesenchymal stem cells from intrahepatic and identical bone marrow., PMID:34343826

Efficacy of expressions of Arg-1, Hep Par-1, and CK19 in the diagnosis of the primary hepatocellular carcinoma subtypes and exclusion of the metastases., PMID:34254284

HER2 Signaling in Breast Cancer., PMID:33983573

Identification of novel autoantibodies in ascites of relapsed paclitaxel-resistant gastric cancer with peritoneal metastasis using immunome protein microarrays and proteomics., PMID:33896831

Prognostic Role for CYFRA 21-1 in Patients With Advanced-stage NSCLC Treated With Bevacizumab Plus Chemotherapy., PMID:33813413

Molecular phenotypes of circulating tumor cells and efficacy of nivolumab treatment in patients with head and neck squamous cell carcinoma., PMID:33299117

Antigen-agnostic microfluidics-based circulating tumor cell enrichment and downstream molecular characterization., PMID:33095819

DLL4 restores damaged liver by enhancing hBMSC differentiation into cholangiocytes., PMID:32622343

Standard ultra-staging compared to one-step nucleic acid amplification for the detection of sentinel lymph node metastasis in endometrial cancer patients: a retrospective cohort comparison., PMID:31996396

Three-dimensional visualization of cleared human pancreas cancer reveals that sustained epithelial-to-mesenchymal transition is not required for venous invasion., PMID:31700162

Real-time quantitative PCR detection of circulating tumor cells using tag DNA mediated signal amplification strategy., PMID:29885605

Retrospective study of paraneoplastic neurological syndromes in a Chinese Han population from Shandong, East China., PMID:29355452

Simultaneous Multiplexed Imaging of mRNA and Proteins with Subcellular Resolution in Breast Cancer Tissue Samples by Mass Cytometry., PMID:29289569

Multiplex Gene Expression Profiling of In Vivo Isolated Circulating Tumor Cells in High-Risk Prostate Cancer Patients., PMID:29122836

Validation of a Novel Diagnostic Kit Using the Semidry Dot-Blot Method to Detect Metastatic Lymph Nodes in Breast Cancer: Distinguishing Macrometastases From Nonmacrometastases., PMID:28778378

Accession of Tumor Heterogeneity by Multiplex Transcriptome Profiling of Single Circulating Tumor Cells., PMID:27630154

Defective DNA methylation in salivary gland epithelial acini from patients with Sjögren's syndrome is associated with SSB gene expression, anti-SSB/LA detection, and lymphocyte infiltration., PMID:26725749

Cytokeratin19 induced by HER2/ERK binds and stabilizes HER2 on cell membranes., PMID:25342465

Ductal adenocarcinoma of the pancreas usually retained SMAD4 and p53 protein status as well as expression of epithelial-to-mesenchymal transition markers and cell cycle regulators at the stage of liver metastasis., PMID:25119169

Comparison of molecular and immunocytochemical methods for detection of disseminated tumor cells in bone marrow from early breast cancer patients., PMID:25023626

A synthetic connexin 43 mimetic peptide augments corneal wound healing., PMID:23876491

Prognostic and predictive value of circulating tumor cell analysis in colorectal cancer patients., PMID:23146106

Development of a molecular multimarker assay for the analysis of circulating tumor cells in adenocarcinoma patients., PMID:22783565

Multimarker Analysis of Circulating Tumor Cells in Peripheral Blood of Metastatic Breast Cancer Patients: A Step Forward in Personalized Medicine., PMID:22553466

Multimarker gene analysis of circulating tumor cells in pancreatic cancer patients: a feasibility study., PMID:22270149

Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma., PMID:21517111

Comparative transcriptional profiling of the limbal epithelial crypt demonstrates its putative stem cell niche characteristics., PMID:20920242

Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype., PMID:19087274

Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors., PMID:15272279

Hashimoto's thyroiditis with papillary thyroid carcinoma (PTC)-like nuclear alterations express molecular markers of PTC., PMID:15228442

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1860

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human KRT19/CK19 Nanobody (SAA1367) [RHC36001]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only